ImmunityBio, Inc. is a clinical-stage biotechnology company developing next-generation immunotherapies and vaccines to bolster the immune system against cancer and infectious diseases.
Notice Date
December 8, 2025
—
January 30, 2026
Woburn
Massachusetts
Boston